Notes from the Floor: Bloom Burton & Co., Day 2

The Bloom Burton & Co. Healthcare Investor Conference just wrapped up in Toronto, and the Investing News Network (INN) was on site to provide coverage. 

Held from May 2 to May 3 at the Sheraton Center Hotel, the healthcare-focused event featured around 60 Canadian publicly traded and venture-backed private companies, along with promising pre-venture companies.

INN spent the second day of the show attending company and analyst presentations, as well as speaking with participants. Follow along below for a pictorial overview of day two of the conference, or click here to see what happened on day one.

Day two began with a keynote presentation from Rajeev Shah of RA Capital Management. Shah spoke about how to build value for disruptive technologies in today’s world.

Rajeev Shah of RA Capital kicks of day two with a keynote on how to build value for disruptive technologies in a competitive world #BBHIC2018 pic.twitter.com/rvHBisln29

— Bloom Burton & Co (@bloomburton) May 3, 2018

Company presentations took up the next chunk of the day. Execs from companies like Trillium Therapeutics (TSX:TRIL,NASDAQ:TRIL), LED Medical Diagnostics (TSXV:LMD) and Bellus Health (TSX:BLU) took the stage to share ideas.

Wow so many old friends and new ideas – healthcare moves fast for those not watching #BBHIC2018

— JBruce (@jambrucehealth) May 3, 2018

Lunch time brought a well-attended panel moderated by Brian Bloom, Bloom Burton & Co.’s co-founder, chairman and CEO.

The talk was focused on investing in commercial-stage healthcare companies and featured: Ruoxi Chen of Warburg Pincus; Jeffrey Schwartz of Bain Capital Life Sciences; Thecia Sweeney of Birch Hill Equity Partners; Tadd Wessel of Petrichor Healthcare Capital Management; and Jason Wild of JW Asset Management. All were able to share insightful comments about the topic.

#BBHIC2018 Investing in Commercial Stage Healthcare Companies Panel is in full swing at the #BBHIC2018 @bloomburton pic.twitter.com/ZWJUgK9kVW

— INN Life Science (@INN_LifeScience) May 3, 2018

The generic market is tough right now says Ruoxi Chen about the #pharmaceutical industry on the in the Investing in Commercial Stage Healthcare Companies Panel at the #BBHIC2018 @bloomburton

— INN Life Science (@INN_LifeScience) May 3, 2018

The pendulum is swinging back towards development says Jeffrey Schwartz in respect to interest in the pharmaceutical industry, in the Investing in Commercial Stage Healthcare Companies Panel at the #BBHIC2018 @bloomburton

— INN Life Science (@INN_LifeScience) May 3, 2018

There’s still money to be made in generics but my belief is the smaller guys can be successful says Jason Wild in respect to the generic pharmaceutical industry, during the Investing in Commercial Stage Healthcare Companies at the #BBHIC2018 @bloomburton

— INN Life Science (@INN_LifeScience) May 3, 2018

We’re ultimately trying to add to the current #LN therapy option for patients says Celia Economides, as opposed to replacing the standard treatment @AuriniaPharma @bloomburton #BBHIC2018

— INN Life Science (@INN_LifeScience) May 3, 2018

The afternoon brought more company presentations, and the INN team was able to take in a few. Presenters during the second half of the day included Aurinia Pharmaceuticals (TSX:AUP,NASDAQ:AUPH) and Immunovaccine (TSX:IMV).

Here is Celia Economides presenting for @AuriniaPharma at the #BBHIC2018 @bloomburton pic.twitter.com/wYX0zF6NAd

— INN Life Science (@INN_LifeScience) May 3, 2018

@Immunovaccine just announced today the company intends to list the the NASDAQ. Here at the #BBHIC2018 CFO Pierre Labbé is presenting @bloomburton pic.twitter.com/OEaackj5FD

— INN Life Science (@INN_LifeScience) May 3, 2018

Overall, attendees left the show feeling invigorated and satisfied with the two-day event. Stay tuned for INN’s audio interviews from the conference, and see you at the Bloom Burton & Co. conference in 2019!

With over 1,100 registrants it’s @bloomburton #BBHIC2018 biggest year. This is the main hall, which was busy even when all presentations were ongoing. Thank you to the organizers for a great conference! pic.twitter.com/aQzBvjj9TM

— INN Life Science (@INN_LifeScience) May 3, 2018

Don’t forget to follow us @INN_LifeScience for real-time updates!

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.